• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,532.96 325.72
( 0.44%)
Global Indices
Nasdaq
46,043.89 -202.27
(-0.44%)
Dow Jones
6,628.50 -17.20
(-0.26%)
Hang Seng
53,297.18 -1,942.22
(-3.52%)
Nikkei 225
9,927.54 -135.96
(-1.35%)
Forex
USD-INR
92.72 0.33
(0.36%)
EUR-INR
106.76 0.38
(0.35%)
GBP-INR
123.58 0.43
(0.35%)
JPY-INR
0.58 0.00
(0.28%)

EQUITY - MARKET SCREENER

Marksans Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524404
INE750C01026
32.9918134
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MARKSANS
29.65
7309.53
EPS(TTM)
Face Value()
Div & Yield %
5.44
1
0.5
 

As on: Mar 20, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
169.75 8.45 82814 29.65
Stock Price Details
Open Price() 161.70
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 171.95
Today's Low () 161.70
52-Week High () 270.6
152-Week Low () 157.25
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 0.50
Eps 5.44
Book Value 32.9918134
Market Cap (.Cr) 7,309.53
Face Value 1
Market Lot 1
AGM Date Aug
Book Closure Date
ISIN No. INE750C01026


News
Marksans Pharma gains after Q3 PAT rises 8% YoY to Rs 113 crore
Marksans Pharma consolidated net profit rises 8.26% in the December 2025 quarter
Marksans Pharma incorporates two subsidiaries in Ireland and Canada
Marksans Pharma to announce Quarterly Result
Relonchem receives UK MHRA's approval for Cetirizine Dihydrochloride 1 mg/ml Oral Solution
Marksans Pharma receives USFDA approval for Loperamide Hydrochloride tablets
Marksans Pharma’s arm gets USFDA approval for Loperamide Hydrochloride 2mg tablets
Relonchem receives UK MHRA's marketing approval for two products
Marksans Pharma consolidated net profit rises 1.58% in the September 2025 quarter
Barometers trade with strong gains; consumer durable shares rally
More
Corporate Details
Incoporation Year   : 1992
Chairman : Mark Saldanha
Bussiness Group : Indian Private
Registered Office
Marksans Pharma Ltd
11th Flr GRANDEUR Oshiwara,
Veera Desai Extn Rd Andheri(W),
Mumbai,
Maharashtra-400053
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-40012000
Fax:91-22-40012011
Fax:91-22-66317458
E-Mail : companysecretary@marksanspharma.com ; info@marksan
URL : http://www.marksanspharma.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE HC
  • BSE SmallCap
No Data Found...!
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi